NTEC - Neose Technologies Inc.

9.63
0   0%

Share volume: 0
Last Updated: 08-03-2021

PREVIOUS CLOSE
CHG
CHG%
$9.63
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Historical prices Events Documents Notes Dividends
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
6.41%
1 Month
-31.02%
3 Months
-37.63%
6 Months
-48.00%
1 Year
-70.91%
2 Year
-76.28%
Key data
Stock price
$9.63
P/E Ratio 
0.00
DAY RANGE
$9.59 - $11.10
EPS 
$0.00
52 WEEK RANGE
$8.80 - $36.80
52 WEEK CHANGE
-$0.72
MARKET CAP 
70.982 M
YIELD 
N/A
SHARES OUTSTANDING 
7.371 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
1.17
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$5,618,437
AVERAGE 30 VOLUME 
$2,095,733
Company detail
CEO: Jeffrey Meckler
Region: US
Website: intecpharma.com
Employees: 40
IPO year: -
Issue type: Common Stock
Market: NASDAQ
Industry:
Sector:

Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The Company's Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and specific release mechanism.

Recent news